Charles A Bancroft Bristol Myers Squibb CO (BMY) insider trading activity

Charles A Bancroft is EVP, Head of Integration of BRISTOL MYERS SQUIBB CO. Currently has a direct ownership of 137,534 shares of BMY, which is worth approximately $7.88 Million. The most recent transaction as insider was on Dec 02, 2016, when has been sold 6,403 shares (Common Stock, $0.10 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 138K

0% 3M change

0% 12M change

Total Value Held $7.88 Million

Charles A Bancroft Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 02 2016	BUY Exercise of conversion of derivative security	-	6,403 Added 3.21%	192,801 Common Stock, $0.10 pa...
Nov 01 2016	SELL Payment of exercise price or tax liability	$70,917 $50.8 p/Share	1,396 Reduced 0.74%	186,398 Common Stock, $0.10 pa...
Nov 01 2016	BUY Exercise of conversion of derivative security	-	3,100 Added 1.62%	187,794 Common Stock, $0.10 pa...
May 20 2016	SELL Open market or private sale	$2,137,929 $70.79 p/Share	30,201 Reduced 14.05%	184,694 Common Stock, $0.10 pa...
Mar 10 2016	SELL Other acquisition or disposition	-	92 Reduced 0.05%	193,277 Common Stock, $0.10 pa...
Mar 10 2016	SELL Payment of exercise price or tax liability	$2,365,569 $64.94 p/Share	36,427 Reduced 14.11%	221,724 Common Stock, $0.10 pa...
Mar 10 2016	BUY Other acquisition or disposition	-	5,378 Added 2.84%	184,161 Common Stock, $0.10 pa...
Mar 10 2016	BUY Exercise of conversion of derivative security	-	75,618 Added 23.43%	247,158 Common Stock, $0.10 pa...
Mar 06 2016	SELL Payment of exercise price or tax liability	$416,409 $64.71 p/Share	6,435 Reduced 3.64%	170,417 Common Stock, $0.10 pa...
Mar 06 2016	BUY Other acquisition or disposition	-	6,968 Added 3.79%	176,852 Common Stock, $0.10 pa...
Mar 06 2016	BUY Exercise of conversion of derivative security	-	7,324 Added 4.13%	169,884 Common Stock, $0.10 pa...

Also insider at

KOD

Kodiak Sciences Inc. Healthcare

CAB